Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alopecia | 2 | 2024 | 414 | 1.240 |
Why?
|
Spondylosis | 2 | 2017 | 84 | 1.050 |
Why?
|
Negotiating | 2 | 2024 | 152 | 1.010 |
Why?
|
Surgicenters | 1 | 2024 | 38 | 0.930 |
Why?
|
Spinal Cord Diseases | 2 | 2017 | 290 | 0.890 |
Why?
|
Minoxidil | 1 | 2024 | 35 | 0.890 |
Why?
|
Spinal Cord Neoplasms | 2 | 2016 | 258 | 0.880 |
Why?
|
Oropharyngeal Neoplasms | 2 | 2019 | 492 | 0.880 |
Why?
|
Aerosols | 3 | 2021 | 633 | 0.860 |
Why?
|
Head and Neck Neoplasms | 6 | 2019 | 2921 | 0.850 |
Why?
|
Finasteride | 1 | 2024 | 86 | 0.840 |
Why?
|
Cervical Vertebrae | 3 | 2017 | 974 | 0.780 |
Why?
|
Medicare | 9 | 2023 | 6823 | 0.750 |
Why?
|
Platelet-Rich Plasma | 1 | 2024 | 179 | 0.740 |
Why?
|
Reimbursement, Incentive | 3 | 2021 | 541 | 0.730 |
Why?
|
Medicare Part B | 1 | 2022 | 115 | 0.720 |
Why?
|
Carcinoma, Squamous Cell | 5 | 2019 | 4044 | 0.690 |
Why?
|
Hypoglossal Nerve | 2 | 2022 | 110 | 0.650 |
Why?
|
Otolaryngology | 4 | 2020 | 698 | 0.640 |
Why?
|
X-Linked Inhibitor of Apoptosis Protein | 1 | 2019 | 62 | 0.640 |
Why?
|
Spinal Fractures | 2 | 2015 | 703 | 0.630 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 5 | 2020 | 325 | 0.630 |
Why?
|
Financial Management | 1 | 2020 | 161 | 0.620 |
Why?
|
Cochlear Implantation | 1 | 2023 | 317 | 0.610 |
Why?
|
Hospital Charges | 1 | 2020 | 345 | 0.610 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2019 | 202 | 0.600 |
Why?
|
Cochlear Implants | 1 | 2023 | 342 | 0.600 |
Why?
|
Electric Stimulation Therapy | 2 | 2022 | 635 | 0.570 |
Why?
|
Neck Dissection | 1 | 2019 | 200 | 0.560 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 2019 | 243 | 0.550 |
Why?
|
Neurosurgical Procedures | 3 | 2018 | 2074 | 0.550 |
Why?
|
Outsourced Services | 1 | 2016 | 20 | 0.540 |
Why?
|
Quality of Life | 9 | 2023 | 13462 | 0.540 |
Why?
|
Surgery, Plastic | 1 | 2023 | 651 | 0.520 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2019 | 263 | 0.520 |
Why?
|
Morpholines | 1 | 2019 | 577 | 0.520 |
Why?
|
Tracheostomy | 1 | 2020 | 429 | 0.510 |
Why?
|
Specialties, Surgical | 1 | 2020 | 391 | 0.510 |
Why?
|
Thoracic Vertebrae | 2 | 2017 | 614 | 0.490 |
Why?
|
Facial Paralysis | 3 | 2023 | 346 | 0.480 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 560 | 0.470 |
Why?
|
Disclosure | 1 | 2020 | 756 | 0.460 |
Why?
|
Decompression, Surgical | 2 | 2016 | 603 | 0.450 |
Why?
|
Endoscopy | 3 | 2020 | 1841 | 0.430 |
Why?
|
Lumbar Vertebrae | 3 | 2017 | 1873 | 0.430 |
Why?
|
Thrombospondins | 3 | 2020 | 197 | 0.420 |
Why?
|
Pyrroles | 1 | 2019 | 1119 | 0.410 |
Why?
|
Parkinson Disease | 2 | 2017 | 2895 | 0.410 |
Why?
|
Health Care Costs | 3 | 2023 | 3242 | 0.400 |
Why?
|
Medicine | 1 | 2020 | 942 | 0.390 |
Why?
|
Motivation | 2 | 2021 | 2018 | 0.380 |
Why?
|
Astrocytoma | 1 | 2016 | 772 | 0.370 |
Why?
|
Home Care Services | 1 | 2017 | 660 | 0.360 |
Why?
|
Spinal Fusion | 2 | 2017 | 1302 | 0.350 |
Why?
|
Sleep Apnea, Obstructive | 2 | 2022 | 1896 | 0.350 |
Why?
|
Cross-Sectional Studies | 13 | 2023 | 26318 | 0.330 |
Why?
|
Surgery, Computer-Assisted | 1 | 2017 | 993 | 0.320 |
Why?
|
Costs and Cost Analysis | 3 | 2023 | 1668 | 0.310 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2709 | 0.310 |
Why?
|
Piperazines | 1 | 2019 | 2549 | 0.310 |
Why?
|
United States | 19 | 2024 | 72903 | 0.300 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3100 | 0.300 |
Why?
|
Retrospective Studies | 26 | 2023 | 81514 | 0.300 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3223 | 0.300 |
Why?
|
Lymph Nodes | 1 | 2019 | 3454 | 0.290 |
Why?
|
Humans | 67 | 2024 | 765968 | 0.290 |
Why?
|
Multiple Myeloma | 2 | 2015 | 5197 | 0.290 |
Why?
|
Papillomavirus Infections | 1 | 2019 | 1640 | 0.290 |
Why?
|
Telemedicine | 2 | 2022 | 3105 | 0.280 |
Why?
|
Ossification, Heterotopic | 2 | 2018 | 239 | 0.250 |
Why?
|
Databases, Factual | 2 | 2019 | 8067 | 0.250 |
Why?
|
Patient Acceptance of Health Care | 1 | 2017 | 3230 | 0.220 |
Why?
|
Imaging, Three-Dimensional | 1 | 2017 | 4034 | 0.220 |
Why?
|
Insurance, Health | 3 | 2022 | 2521 | 0.220 |
Why?
|
Fees and Charges | 1 | 2024 | 189 | 0.210 |
Why?
|
5-alpha Reductase Inhibitors | 1 | 2024 | 114 | 0.200 |
Why?
|
Kaplan-Meier Estimate | 3 | 2019 | 6499 | 0.200 |
Why?
|
Physicians | 1 | 2020 | 4588 | 0.200 |
Why?
|
Middle Aged | 25 | 2023 | 223009 | 0.200 |
Why?
|
Relative Value Scales | 2 | 2020 | 85 | 0.200 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2024 | 394 | 0.200 |
Why?
|
Biological Products | 2 | 2022 | 942 | 0.200 |
Why?
|
Hospitals | 4 | 2023 | 3888 | 0.200 |
Why?
|
Facial Nerve Injuries | 1 | 2022 | 64 | 0.200 |
Why?
|
Cisplatin | 2 | 2019 | 1658 | 0.200 |
Why?
|
Male | 30 | 2024 | 363698 | 0.190 |
Why?
|
Female | 33 | 2024 | 396112 | 0.190 |
Why?
|
Voice Quality | 2 | 2020 | 226 | 0.190 |
Why?
|
Lymphatic Metastasis | 2 | 2019 | 2887 | 0.180 |
Why?
|
Cosmetic Techniques | 1 | 2023 | 149 | 0.180 |
Why?
|
Aged | 20 | 2023 | 171117 | 0.180 |
Why?
|
Hypersensitivity | 2 | 2021 | 1168 | 0.180 |
Why?
|
Adenoidectomy | 1 | 2022 | 171 | 0.180 |
Why?
|
Voice Training | 1 | 2020 | 44 | 0.170 |
Why?
|
Legislation as Topic | 1 | 2020 | 76 | 0.170 |
Why?
|
Leuprolide | 1 | 2022 | 312 | 0.170 |
Why?
|
Compensation and Redress | 1 | 2020 | 66 | 0.170 |
Why?
|
Survival Rate | 3 | 2019 | 12795 | 0.170 |
Why?
|
Olfactory Mucosa | 1 | 2021 | 101 | 0.170 |
Why?
|
Cautery | 1 | 2020 | 73 | 0.170 |
Why?
|
Fee Schedules | 1 | 2020 | 86 | 0.170 |
Why?
|
T-Lymphocytes | 2 | 2017 | 10261 | 0.170 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2024 | 453 | 0.170 |
Why?
|
Hyaluronic Acid | 1 | 2023 | 484 | 0.170 |
Why?
|
Neoplasm Staging | 3 | 2019 | 11206 | 0.160 |
Why?
|
Otorhinolaryngologic Diseases | 1 | 2020 | 96 | 0.160 |
Why?
|
Radiation Injuries | 2 | 2017 | 1181 | 0.160 |
Why?
|
Anti-Anxiety Agents | 1 | 2022 | 402 | 0.160 |
Why?
|
Baculoviridae | 1 | 2019 | 115 | 0.160 |
Why?
|
Antineoplastic Agents | 2 | 2019 | 13648 | 0.160 |
Why?
|
Suction | 1 | 2020 | 265 | 0.160 |
Why?
|
Marketing of Health Services | 1 | 2020 | 151 | 0.160 |
Why?
|
Caspase 8 | 1 | 2019 | 198 | 0.160 |
Why?
|
Hair | 1 | 2022 | 508 | 0.150 |
Why?
|
Treatment Outcome | 10 | 2023 | 65188 | 0.150 |
Why?
|
Ambulatory Care Facilities | 1 | 2024 | 939 | 0.150 |
Why?
|
Cordotomy | 1 | 2018 | 7 | 0.150 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2019 | 195 | 0.150 |
Why?
|
Dysphonia | 1 | 2020 | 144 | 0.150 |
Why?
|
Rhinoplasty | 1 | 2022 | 241 | 0.150 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2020 | 498 | 0.150 |
Why?
|
Paranasal Sinuses | 1 | 2020 | 267 | 0.140 |
Why?
|
Cost Control | 1 | 2020 | 624 | 0.140 |
Why?
|
Failed Back Surgery Syndrome | 1 | 2017 | 21 | 0.140 |
Why?
|
Radiosurgery | 2 | 2017 | 1328 | 0.140 |
Why?
|
Nasopharynx | 1 | 2020 | 419 | 0.140 |
Why?
|
Radiation Tolerance | 1 | 2019 | 475 | 0.140 |
Why?
|
State Government | 1 | 2020 | 388 | 0.140 |
Why?
|
Access to Information | 1 | 2020 | 317 | 0.140 |
Why?
|
Temporal Bone | 2 | 2018 | 683 | 0.140 |
Why?
|
Medicare Part D | 1 | 2021 | 355 | 0.130 |
Why?
|
Laryngeal Diseases | 1 | 2020 | 248 | 0.130 |
Why?
|
Tongue | 1 | 2020 | 405 | 0.130 |
Why?
|
Cost Savings | 2 | 2021 | 904 | 0.130 |
Why?
|
Nasal Polyps | 1 | 2022 | 412 | 0.130 |
Why?
|
Nose | 1 | 2020 | 519 | 0.130 |
Why?
|
Cohort Studies | 6 | 2019 | 41649 | 0.130 |
Why?
|
Laryngoscopy | 2 | 2020 | 686 | 0.130 |
Why?
|
Neovascularization, Pathologic | 2 | 2017 | 2631 | 0.130 |
Why?
|
Complex Regional Pain Syndromes | 1 | 2017 | 123 | 0.130 |
Why?
|
Cough | 1 | 2020 | 597 | 0.130 |
Why?
|
Necrosis | 2 | 2017 | 1617 | 0.130 |
Why?
|
Postoperative Complications | 5 | 2018 | 15747 | 0.120 |
Why?
|
Quality-Adjusted Life Years | 1 | 2022 | 1737 | 0.120 |
Why?
|
Spondylolisthesis | 1 | 2017 | 173 | 0.120 |
Why?
|
Vocal Cords | 1 | 2020 | 520 | 0.120 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2020 | 8611 | 0.120 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2017 | 254 | 0.120 |
Why?
|
Radiography | 2 | 2015 | 6919 | 0.120 |
Why?
|
Tomography, X-Ray Computed | 2 | 2018 | 20659 | 0.120 |
Why?
|
Reimbursement Mechanisms | 1 | 2020 | 672 | 0.120 |
Why?
|
Vocal Cord Paralysis | 1 | 2018 | 275 | 0.120 |
Why?
|
Surgical Flaps | 1 | 2023 | 1677 | 0.110 |
Why?
|
Cranial Irradiation | 1 | 2017 | 385 | 0.110 |
Why?
|
Prescription Drugs | 1 | 2021 | 634 | 0.110 |
Why?
|
Rhinitis | 1 | 2022 | 752 | 0.110 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2019 | 1776 | 0.110 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2019 | 3608 | 0.110 |
Why?
|
Postoperative Care | 1 | 2020 | 1470 | 0.110 |
Why?
|
Immunomodulation | 1 | 2017 | 547 | 0.110 |
Why?
|
Pandemics | 4 | 2020 | 8703 | 0.110 |
Why?
|
Outpatients | 1 | 2021 | 1595 | 0.110 |
Why?
|
Bone Screws | 1 | 2017 | 532 | 0.110 |
Why?
|
Apoptosis | 3 | 2019 | 9514 | 0.110 |
Why?
|
Transforming Growth Factor beta | 2 | 2020 | 1995 | 0.110 |
Why?
|
Spinal Diseases | 1 | 2018 | 559 | 0.110 |
Why?
|
Neoplasms | 1 | 2022 | 22340 | 0.100 |
Why?
|
Patient Readmission | 2 | 2017 | 3286 | 0.100 |
Why?
|
Papillomaviridae | 1 | 2019 | 1141 | 0.100 |
Why?
|
Polysomnography | 1 | 2020 | 1859 | 0.100 |
Why?
|
Electrodes, Implanted | 1 | 2017 | 830 | 0.100 |
Why?
|
Delivery of Health Care | 2 | 2021 | 5370 | 0.100 |
Why?
|
Fluoroscopy | 1 | 2017 | 947 | 0.100 |
Why?
|
Sinusitis | 1 | 2022 | 995 | 0.100 |
Why?
|
Adult | 14 | 2023 | 223044 | 0.100 |
Why?
|
Linear Models | 2 | 2019 | 5876 | 0.100 |
Why?
|
Cardiology | 1 | 2023 | 1702 | 0.100 |
Why?
|
Information Dissemination | 1 | 2020 | 1142 | 0.100 |
Why?
|
Hyperglycemia | 1 | 2020 | 1393 | 0.100 |
Why?
|
Prosthesis Failure | 1 | 2017 | 1191 | 0.090 |
Why?
|
Propensity Score | 1 | 2019 | 1968 | 0.090 |
Why?
|
Pain Measurement | 2 | 2018 | 3561 | 0.090 |
Why?
|
Facial Nerve | 2 | 2023 | 277 | 0.090 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2017 | 1499 | 0.090 |
Why?
|
Cell Line, Tumor | 4 | 2020 | 17075 | 0.090 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2014 | 499 | 0.090 |
Why?
|
Hospitalists | 1 | 2014 | 297 | 0.090 |
Why?
|
Medical Staff, Hospital | 1 | 2014 | 601 | 0.090 |
Why?
|
Trauma Centers | 1 | 2016 | 952 | 0.080 |
Why?
|
Reoperation | 2 | 2017 | 4294 | 0.080 |
Why?
|
Spinal Cord Injuries | 1 | 2017 | 927 | 0.080 |
Why?
|
Hospitals, Pediatric | 2 | 2016 | 1846 | 0.080 |
Why?
|
Patient Satisfaction | 2 | 2023 | 3475 | 0.080 |
Why?
|
Body Height | 1 | 2015 | 1562 | 0.080 |
Why?
|
Disease-Free Survival | 1 | 2019 | 6832 | 0.080 |
Why?
|
Diabetes Complications | 1 | 2015 | 1316 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2019 | 2942 | 0.080 |
Why?
|
Spine | 1 | 2015 | 1128 | 0.080 |
Why?
|
Antigens, Neoplasm | 1 | 2016 | 2002 | 0.080 |
Why?
|
Medical Errors | 1 | 2017 | 1260 | 0.080 |
Why?
|
Disease Progression | 2 | 2015 | 13632 | 0.080 |
Why?
|
Patient Admission | 1 | 2016 | 1365 | 0.080 |
Why?
|
Cardiac Surgical Procedures | 1 | 2023 | 3675 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2019 | 4348 | 0.070 |
Why?
|
Patient Discharge | 2 | 2017 | 3461 | 0.070 |
Why?
|
Orthopedic Procedures | 1 | 2017 | 1280 | 0.070 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8529 | 0.070 |
Why?
|
Follow-Up Studies | 3 | 2018 | 39193 | 0.070 |
Why?
|
Prognosis | 2 | 2019 | 29922 | 0.070 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2022 | 3719 | 0.070 |
Why?
|
Survival Analysis | 1 | 2019 | 10070 | 0.070 |
Why?
|
Length of Stay | 2 | 2017 | 6485 | 0.070 |
Why?
|
Cell Proliferation | 2 | 2019 | 10429 | 0.070 |
Why?
|
Cadaver | 2 | 2020 | 1359 | 0.060 |
Why?
|
Brain Neoplasms | 2 | 2017 | 9071 | 0.060 |
Why?
|
Comorbidity | 2 | 2020 | 10563 | 0.060 |
Why?
|
Endothelium, Vascular | 1 | 2017 | 4427 | 0.060 |
Why?
|
Insurance Coverage | 1 | 2016 | 1944 | 0.060 |
Why?
|
Drug Synergism | 2 | 2019 | 1749 | 0.060 |
Why?
|
Prospective Studies | 3 | 2023 | 54802 | 0.050 |
Why?
|
Mice | 6 | 2020 | 81819 | 0.050 |
Why?
|
Smiling | 1 | 2023 | 71 | 0.050 |
Why?
|
Wounds and Injuries | 1 | 2016 | 2511 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15398 | 0.050 |
Why?
|
Smoking | 1 | 2019 | 9081 | 0.050 |
Why?
|
Denervation | 1 | 2023 | 265 | 0.050 |
Why?
|
DNA | 1 | 2015 | 7202 | 0.050 |
Why?
|
Referral and Consultation | 1 | 2014 | 3615 | 0.050 |
Why?
|
Middle Ear Ventilation | 1 | 2022 | 101 | 0.050 |
Why?
|
Inflammation | 1 | 2020 | 10850 | 0.040 |
Why?
|
Stroboscopy | 1 | 2020 | 62 | 0.040 |
Why?
|
Risk Assessment | 2 | 2019 | 24282 | 0.040 |
Why?
|
Emergency Service, Hospital | 2 | 2017 | 7875 | 0.040 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2023 | 511 | 0.040 |
Why?
|
Brain | 2 | 2017 | 27171 | 0.040 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2020 | 281 | 0.040 |
Why?
|
Ohio | 1 | 2020 | 320 | 0.040 |
Why?
|
Disease Models, Animal | 4 | 2020 | 18293 | 0.040 |
Why?
|
Smell | 1 | 2021 | 259 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11868 | 0.040 |
Why?
|
Animals | 6 | 2020 | 168764 | 0.040 |
Why?
|
Time Factors | 1 | 2019 | 40065 | 0.040 |
Why?
|
Perception | 1 | 2023 | 1205 | 0.030 |
Why?
|
Karnofsky Performance Status | 1 | 2017 | 163 | 0.030 |
Why?
|
Head | 1 | 2023 | 925 | 0.030 |
Why?
|
Risk Factors | 3 | 2020 | 74840 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2019 | 720 | 0.030 |
Why?
|
Otologic Surgical Procedures | 1 | 2018 | 148 | 0.030 |
Why?
|
Health Facilities | 1 | 2021 | 577 | 0.030 |
Why?
|
Drugs, Generic | 1 | 2021 | 456 | 0.030 |
Why?
|
Genes, erbB-2 | 1 | 2016 | 160 | 0.030 |
Why?
|
Particle Size | 1 | 2020 | 1631 | 0.030 |
Why?
|
Chronic Disease | 2 | 2022 | 9347 | 0.030 |
Why?
|
District of Columbia | 1 | 2016 | 159 | 0.030 |
Why?
|
Pregnancy | 1 | 2018 | 30260 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2020 | 22332 | 0.030 |
Why?
|
Chick Embryo | 1 | 2017 | 964 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2018 | 12056 | 0.030 |
Why?
|
Antigen Presentation | 1 | 2019 | 1250 | 0.030 |
Why?
|
Osteotomy | 1 | 2018 | 833 | 0.030 |
Why?
|
Postoperative Period | 1 | 2017 | 1816 | 0.020 |
Why?
|
Logistic Models | 2 | 2018 | 13266 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1461 | 0.020 |
Why?
|
Gene Amplification | 1 | 2016 | 1091 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2017 | 18973 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2015 | 59489 | 0.020 |
Why?
|
Antigens, CD | 1 | 2020 | 4025 | 0.020 |
Why?
|
Antidepressive Agents | 1 | 2022 | 2897 | 0.020 |
Why?
|
Massachusetts | 1 | 2022 | 8875 | 0.020 |
Why?
|
Spinal Cord | 1 | 2017 | 1784 | 0.020 |
Why?
|
Health Expenditures | 1 | 2022 | 2387 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2015 | 3089 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2015 | 1820 | 0.020 |
Why?
|
Particulate Matter | 1 | 2020 | 2624 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 36532 | 0.020 |
Why?
|
Regression Analysis | 1 | 2016 | 6322 | 0.020 |
Why?
|
Anxiety | 1 | 2022 | 4671 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2015 | 4108 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2016 | 2054 | 0.020 |
Why?
|
Macrophages | 1 | 2020 | 5772 | 0.020 |
Why?
|
Child | 3 | 2022 | 80564 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2020 | 14448 | 0.020 |
Why?
|
Cell Movement | 1 | 2017 | 5194 | 0.010 |
Why?
|
Infant, Newborn | 2 | 2016 | 26346 | 0.010 |
Why?
|
Infant | 2 | 2016 | 36386 | 0.010 |
Why?
|
Prevalence | 1 | 2020 | 15842 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2017 | 12509 | 0.010 |
Why?
|
Child, Preschool | 2 | 2016 | 42500 | 0.010 |
Why?
|
Depression | 1 | 2022 | 8237 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11022 | 0.010 |
Why?
|
Boston | 1 | 2014 | 9338 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2018 | 15880 | 0.010 |
Why?
|
Young Adult | 2 | 2017 | 59889 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2017 | 11888 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2016 | 6364 | 0.010 |
Why?
|
Melanoma | 1 | 2016 | 5719 | 0.010 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 5389 | 0.010 |
Why?
|
Adolescent | 2 | 2016 | 88835 | 0.010 |
Why?
|
Hospitalization | 1 | 2014 | 10808 | 0.010 |
Why?
|
Signal Transduction | 1 | 2017 | 23601 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2016 | 13451 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2016 | 21056 | 0.000 |
Why?
|